{"data":{"issuanceinfo":{"industrycode":"204005","industry":"醫療保健","ipoprice":{"ceiling":"20.800","floor":"20.100"},"ipodate":{"start":"2019-10-28 00:00:00","end":"2019-10-31 00:00:00"},"minimumcapital":"4201.92","subscribed":"267.97","marketcap":"33.28億","H_marketcap":"8.32億","pe":"50.18","codesrate":"30.00","link":"https://staticpdf.iqdii.com/stockdata/notice/01501/2019/2019102800008_c.pdf","ipopricing":"20.800","resultdate":"2019-11-07 00:00:00","enddate":"2019-10-31 00:00:00","listeddate":"2019-11-08 00:00:00","issuenumber":"4000.00萬","issuenumberhK":"2000.00萬","issuenumberother":"2000.00萬","grayprice":"25.75","sponsors":"交銀國際(亞洲)有限公司","raisemoney":"75800.00萬","use":"1、凈所得款項中的約34.1%或258.5百萬港元，擬用于建設位于上海市嘉定區的研發中心及其他設施；\n2、凈所得款項中的約14.4%或109.2百萬港元，將用于開發現有管線產品并將其商業化，以及進一步拓展其產品供應；\n3、凈所得款項中的約13.8%或104.6百萬港元，將用于購買額外生產設備并替換現有生產設備及將生產線自動化；\n4、凈所得款項中的約8.7%或65.9百萬港元，將用于擴大其分銷網絡及覆蓋范圍、與當地分銷商的合作及加大營銷力度；\n5、凈所得款項中的約19.6%或148.6百萬港元，將用于為潛在戰略投資（包括收購、合伙及外部授權）提供資金；\n6、凈所得款項中的約9.4%或71.2百萬港元，將用于一般企業用途和為其營運資金提供資金。","shares":200,"leadagent":"交銀國際證券有限公司,招銀國際融資有限公司","bookrunners":"交銀國際證券有限公司,招銀國際融資有限公司","coordinator":"交銀國際證券有限公司,招銀國際融資有限公司","firstDayOpen":"27.00","IsEiio":0,"Interestdays":7,"PENote":"按經審核的最近年度公司股東應占溢利和發行后總股本計算；發行價未確定時，按招股價中間價計算；發行價確定后，按招股定價計算。","OverAllotment":"有","StabilizingManager":"交銀國際證券有限公司","code":"E01501","name":"康德萊醫械","fullname":"上海康德萊醫療器械股份有限公司"},"institutioninfo":{"principaloffice":"中國上海市嘉定區金園一路925號2幢","registrars":"香港中央證券登記有限公司","registrarstel":"(852) 2862 8628","chairman":"梁棟科","secretary":"宋媛,梁瑞冰","telephone":"(8621) 5914 0056","substantialshareholders":"康德萊(26.79%),寧波懷格泰益(15.75%),梁棟科(5.97%)","principalactivities":"公司是中國領先的心內介入器械制造商。","website":"http://www.kdl-int.com"},"managerinfo":[{"managername":"梁棟科","post":"主席、總經理兼執行董事","rankno":1},{"managername":"王彩亮","post":"副總經理兼執行董事","rankno":2},{"managername":"張維鑫","post":"非執行董事","rankno":3}],"investorinfo":[{"institutionname":"Worldwide Healthcare Trust PLC","shareholding":"11,312,800.0","percentage":28.28,"ReleaseDate":"2020-05-08 00:00:00","relatedparty":"OrbiMed Capital LLC","subsidiary":["OrbiMed Funds","Worldwide Healthcare Trust PLC"],"InverstorType":"基金"}],"TotalShareholdingPercentage":28.28},"result":1,"Version":"4.5.190802.46408","ElapsedMilliseconds":507}